nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Alternating chemotherapy for small-cell lung cancer. A twelve-week schedule of six drugs
|
Alba, E. |
|
|
3 |
1 |
p. 31-35 |
artikel |
2 |
Book review
|
de Tribolet, N. |
|
|
3 |
1 |
p. 40 |
artikel |
3 |
Book review
|
Sessa, C. |
|
|
3 |
1 |
p. 58 |
artikel |
4 |
Book review
|
Pedrazzini, A. |
|
|
3 |
1 |
p. 44 |
artikel |
5 |
Book reviews
|
Bosia, C. |
|
|
3 |
1 |
p. 70 |
artikel |
6 |
Chronological age is a multifactorial prognostic variable in patients with Non-Hodgkin’s Lymphoma
|
Ansell, S.M. |
|
|
3 |
1 |
p. 45-50 |
artikel |
7 |
Clinical cancer research: Cancer treatment from the ‘Red Baron’ Dresden
|
Dickman, Steven |
|
|
3 |
1 |
p. 2-4 |
artikel |
8 |
Contents of the next issue
|
|
|
|
3 |
1 |
p. 1 |
artikel |
9 |
Copyright
|
|
|
|
3 |
1 |
p. iv |
artikel |
10 |
Cyclophosphamide, Adriamycin and Cisplatin (CAP) versus Cyclophosphamide, Adriamycin and Vincristin (CAV) in the treatment of advanced ovarian cancer: A randomized study
|
Krommer, C.F. |
|
|
3 |
1 |
p. 37-39 |
artikel |
11 |
Does extra height justify a higher risk of breast cancer?
|
Stoll, B.A. |
|
|
3 |
1 |
p. 29-30 |
artikel |
12 |
Editorial board
|
|
|
|
3 |
1 |
p. iv |
artikel |
13 |
ESMO Award Lecture coupled with Oliva Prize
|
|
|
|
3 |
1 |
p. 6 |
artikel |
14 |
Europeans still undecided on chemoprevention for breast cancer
|
|
|
|
3 |
1 |
p. 5-6 |
artikel |
15 |
Expression of MDR1 and GST-π in human soft tissue sarcomas: Relation to drug resistance and biological aggressiveness
|
Toffoli, G. |
|
|
3 |
1 |
p. 63-69 |
artikel |
16 |
Extramedullary plasmacytoma: Clinical behaviour and response to treatment
|
Soesan, M. |
|
|
3 |
1 |
p. 51-57 |
artikel |
17 |
First Horten Prize to Doll and Peto
|
|
|
|
3 |
1 |
p. 2 |
artikel |
18 |
Free enterprise, nurses and ethical problems in Maastricht
|
|
|
|
3 |
1 |
p. 4-5 |
artikel |
19 |
Immunocytochemical determination of the estrogen-regulated proteins Mr 24, 000, Mr 52, 000 and DF3 breast cancer associated antigen: Clinical value in advanced breast cancer and correlation with estrogen receptor
|
Damstrup, L. |
|
|
3 |
1 |
p. 71-77 |
artikel |
20 |
Instructions to Authors
|
|
|
|
3 |
1 |
p. 89-90 |
artikel |
21 |
In this issue
|
|
|
|
3 |
1 |
p. 1 |
artikel |
22 |
Is interferon-a an active agent in Castleman’s disease?
|
Pavlidis, N.A. |
|
|
3 |
1 |
p. 85-86 |
artikel |
23 |
Neoadjuvant PFL augmented by methotrexate and piritrexim followed by concomitant chemoradiotherapy for advanced head and neck cancer: A feasible and active approach
|
Vokes, E.E. |
|
|
3 |
1 |
p. 79-81 |
artikel |
24 |
Patient treatment on a compassionate basis: Documentation of high adverse drug reaction rate
|
Leyland-Jones, B. |
|
|
3 |
1 |
p. 59-62 |
artikel |
25 |
Perhaps not everyone knows that…
|
|
|
|
3 |
1 |
p. 6-7 |
artikel |
26 |
Phase II study of sulofenur (LY186641) in measurable metastatic renal cancer
|
Weinerman, B. |
|
|
3 |
1 |
p. 83-84 |
artikel |
27 |
Randomized clinical trial with a weekly regimen of 5-FU vs 5-FU + intermediate-dose folinic acid in the treatment of advanced colo-rectal cancer
|
Martoni, A. |
|
|
3 |
1 |
p. 87-88 |
artikel |
28 |
Recognition of tumor-associated antigens by T lymphocytes: From basic concepts to new approaches
|
Cerottini, J.-C. |
|
|
3 |
1 |
p. 11-16 |
artikel |
29 |
Sanctuary site relapse in chemotherapy-treated testicular cancer
|
James, P.P.B. |
|
|
3 |
1 |
p. 41-43 |
artikel |
30 |
Table of Contents
|
|
|
|
3 |
1 |
p. v-vi |
artikel |
31 |
The Annals continues to grow
|
Cavalli, F. |
|
|
3 |
1 |
p. 8 |
artikel |
32 |
Title Page
|
|
|
|
3 |
1 |
p. iii |
artikel |
33 |
Treatment of advanced ovarian cancer: 10 years of experience
|
Neijt, J.P. |
|
|
3 |
1 |
p. 17-27 |
artikel |
34 |
Underground production of cytotoxic drugs?
|
|
|
|
3 |
1 |
p. 6 |
artikel |
35 |
Very high endothelin plasma levels in patients with 5-FU cardiotoxicity
|
Thyss, A. |
|
|
3 |
1 |
p. 87-88 |
artikel |
36 |
Ways to a better treatment of small cell lung cancer—a commentary
|
Østerlind, K. |
|
|
3 |
1 |
p. 9-10 |
artikel |